Open Account
Demo Account
About Us
Real-time Quotes & News
Market Analysis
Economic Calendar
Daily Market Analysis
Trading Platform
Platform Overview
How To Use
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
繁
简
EN
User Login
Open Account
Demo Account
繁
简
EN
User Login
Open Account
Demo Account
About Us
About Aspire
Features of Aspire
Real-time Quotes & News
Real-time Quotes
Real-time News
Market Analysis
Economic Calendar
Market Analysis
Trading Platform
Meta Trader 5
Platform Features
Terms
All Terms
Deposit & Withdrawal
Promotion
FAQ
Contact
About Us
Terms
Metals Market
Trading Platform
Market Analysis
Promotion
FAQ
Contact
繁
简
EN
The commander of U.S. Central Command stated that he is not concerned about the shortage of ammunition to counter Iranian missile and drone attacks.
2026-09-14
The commander of U.S. Central Command stated that he is not concerned about the shortage of ammunition to counter Iranian missile and drone attacks.
Back
Other News
2026-09-13
Former CIA officer David J. Lash, charged with inflating pay via false declarations and stealing public funds, has reached an interim plea agreement with federal prosecutors because the case involves substantial classification material. Prosecutors a
Former CIA officer David J. Lash, charged with inflating pay via false declarations and stealing public funds, has reached an interim plea agreement with federal prosecutors because the case involves substantial classification material. Prosecutors and Lash’s lawyers filed a joint court document on the 10th but did not disclose the agreement’s terms. A federal judge on the 11th extended the deadline to formally indict Lash to Oct. 8 to give parties time to finalize a deal; both sides said a public trial would be highly complex given the classified evidence.
2026-09-13
China's National Healthcare Security Administration said it established a drug-pricing and procurement credit-evaluation system in Aug 2020 and, in a three-year review, found some medical institutions had weak internal controls leading staff to take
China's National Healthcare Security Administration said it established a drug-pricing and procurement credit-evaluation system in Aug 2020 and, in a three-year review, found some medical institutions had weak internal controls leading staff to take repeated, large commercial bribes from discredited suppliers. After a prior Shanghai stent-balloon bribery exposure and reports of a 5,000 yuan-per-stent kickback at Hebei Medical University Second Hospital, the NHSA said that hospital was involved in nine criminal judgments in H2 2025. Hospital staff accepted bribes 46 times; the largest single amount was 16.58 mln yuan, the longest-running scheme lasted 11 years, and the cumulative implicated The amount reached 184 mln yuan.
Chat with us
, powered by
LiveChat